Surgery (Lund)
291 – 300 of 1754
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The liver-first approach for synchronous colorectal liver metastases: A systematic review and meta-analysis of completion rates and effects on survival
2021) In Scandinavian Journal of Surgery(
- Contribution to journal › Scientific review
-
Mark
Liver resection and ablation for squamous cell carcinoma liver metastases
(
- Contribution to journal › Article
-
Mark
Impediments to and impact of checklists on performance of emergency interventions in primary care : an in situ simulation-based randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Difference in Sun Exposure Habits Between Individuals with High and Low Risk of Skin Cancer
(
- Contribution to journal › Article
-
Mark
Autoantibodies against methylglyoxal-modified apolipoprotein B100 and apob100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Response to the Comment on "aLPPS Improves Survival Compared with TSH in Patients Affected of CRLM : Survival Analysis from the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy"
(
- Contribution to journal › Letter
-
Mark
Response to Comment on "aLPPS Improves Survival Compared with TSH in Patients Affected of CRLM - It Is Time to Entry the IDEAL Stage 4?"
(
- Contribution to journal › Letter
-
Mark
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma : An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group
(
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Author response to : European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism
(
- Contribution to journal › Debate/Note/Editorial